Skip to main content

Table 3 Studies investigating specific instrumental activities of daily living domains a

From: Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

Author

Year

MCI criteria

Number of subjects

Mean age, yr (SD)

Mean MMSE score (SD)

IADL measures

Results and effect sizes (Cohen’s d )

Financial capacity: performance-based instruments

Griffith et al. [26]

2003

Petersen

21 MCI

MCI 68.1 (8.8)

MCI 28.4 (1.2)

FCI

NC > MCI > AD; MCI versus NC: d = 1.14, MCI versus AD d = 1.21

CDR 0.5

21 NC

NC 66.7 (7.2)

NC 29.3 (1.0)

22 AD

AD 71.5 (9.2), ns

AD 24.1 (2.6)

Sherod et al. [30]

2009

Petersen

113 MCI

MCI 70.3 (7.4)

MCI 28.1 (1.9)

FCI

NC > MCI > AD; MCI versus NC: d = 1.03, MCI versus AD: d = 0.87

1.5 SD below

85 NC

NC 67.2 (8.2)

NC 29.4 (0.9)

43 AD

AD 73.8 (8.5)

AD 24.6 (2.9)

all significant

Triebel et al. [32]

2009

Petersen

87 MCI

ADcon 74.4 (6.0)

ADcon 27.0 (1.9)

FCI

NC > MCI; ADnon versus NC: d = 0.83, ADcon versus NC: d = 1.83

1.5 SD below

(25 ADcon, 62 ADnon)

ADnon 68.5 (7.5)

ADnon 28.6 (1.4)

76 NC

NC 66.7 (8.5)

NC 29.4 (1.0)

Management of everyday technology: performance-based instruments

Malinowsky et al. [53]

2010

Petersen

33 MCI

MCI 70.5 (8.4)

MCI 27.5 (1.9)

META

NC > MCI > AD, MCI versus NC: d = 0.66, MCI versus AD: d = 1.23

45 NC

NC 73.2 (9.7)

NC 29.3 (1.1)

38 AD

AD 75.3 (9.1)

AD 23.5 (3.3)

Malinowsky et al. [38]

2012

Petersen/Winblad

33 MCI

MCI 70.8 (8.6)

MCI 27.5 (1.9)

META

NC > AD, MCI = NC

42 NC

NC 72.6 (9.7)

NC 29.4 (1.0)

35 AD

AD 75.5 (9.2)

AD 23.5 (3.4)

ns

Management of everyday technology: informant-report rating instruments

Munoz-Neira et al. [54]

2012

Winblad

21 MCI

MCI 71.3 (9.1)

MCI 26.1 (2.5)

T-ADLQ

Total score: NC > MCI > AD, MCI versus NC: d = 0.62, MCI versus AD: d = 1.47

Subscales: NC > MCI on 2 subscales: employment and recreation: d = 0.54, travel: d = 0.55

44 NC

NC 74.1 (7.3)

NC 27.8 (2.3)

63 AD

AD 73.9 (8.7)

AD 17.9 (5.8)

Management of everyday technology: self-report rating instruments

Nygård et al. [55]

2011

Petersen/Winblad

37 MCI

MCI 67.0 (7.47)

MCI 27.5 (2.1)

ETUQ (support of proxy possible for patients with AD and MCI)

Perceived relevance of ET: NC > MCI > AD; MCI versus NC: d = 0.51, MCI versus AD: d = 1.26

44 NC

NC 69.0 (9.58)

NC 29.1 (1.1)

37 AD

AD 72.0 (8.92)

AD 25.4 (2.8)

ns

ns

Perceived difficulty of ET: NC < MCI < AD; MCI versus NC: d = 0.82, MCI versus AD: d = 1.26

Rosenberg et al. [56]

2009

Petersen

30 MCI

MCI 74.0 (6.9)

MCI 27.0 (2.4)

ETUQ (support of proxy possible for patients with AD and MCI)

Perceived relevance of ET: NC > MCI = AD; MCI versus NC: d = 1.66

93 NC

NC 74.0 (7.6)

NC 28.0 (1.7)

Perceived difficulty of ET: NC < MCI < AD; MCI versus NC: d = 0.59, MCI versus AD: d = 1.00

34 AD

AD 73.0 (8.4)

AD 24.0 (3.3)

ns

Driving capacity: performance-based instruments

Wadley et al. [51]

2009

Petersen

46 MCI

MCI 71.3 (7.8)

Not reported

UAB-DA

MCI < NC, d = 0.46

59 NC

NC 67.1 (6.7)

significant

Driving capacity: self-report rating instruments

O’Connor et al. [59]

2010

Petersen/Winblad

304 MCI

MCI 76.8 (6.5)

Not reported

DHQ

(aMCI = naMCI = mdMCI) < NC (driving frequency, driving difficulty, driving space) differed at baseline and faster rates of decline

Driving frequency: aMCI versus NC: d = 0.31, naMCI versus NC: d = 0.24, mdMCI versus NC: d = 0.14

Driving difficulty: aMCI versus NC: d = 0.35, naMCI versus NC: d = 0.36, mdMCI versus NC: d = 0.45

Driving space: aMCI versus NC: d = 0.42, naMCI versus NC: d = 0.51, mdMCI versus NC: d = 0.43

1.5 SD below

(82 aMCI

NC 72.6 (5.3)

140 naMCI

significant

82 mdMCI)

2,051 NC

Shopping capacity: performance-based instruments

Werner et al. [52]

2009

Petersen

30 MCI

MCI 69.3 (7.4)

MCI 27.5 (1.3)

VAPS

MCI < NC; significant subscales: distance d = 0.29, trajectory duration: d = 1.16, duration of pauses: d = 0.89

30 NC

NC 69.6 (7.3)

NC 29.4 (0.7)

ns

significant

  1. aAD, Alzheimer’s disease; ADcon, Converters to Alzheimer’s disease; ADnon, Nonconverters to Alzheimer’s disease; aMCI, Amnestic mild cognitive impairment, both single and multiple domains; CDR, Clinical dementia rating; DHQ, Driving Habits Questionnaire; ETUQ, Everyday Technology Use Questionnaire; FCI, Financial Capacity Instrument; MCI, Mild cognitive impairment; mdMCI, Multiple-domain mild cognitive impairment; NC, Normal control; ns, Nonsignificant; UAB-DA, University of Alabama at Birmingham Driving Assessment; VAPS, Virtual Action Planning Supermarket.